Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unfractionated heparin versus low molecular weight heparin in atrial fibrillation-related ischemic stroke
IRCT2014020213698N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of heparin and low molecular weight heparin calcium in ischemic stroke and Atrial fibrillation (AFib) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Jan 2014; status: completed.
02
Drugs
heparinlow molecular weight heparin calcium
03
Conditions
ischemic strokeAtrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT2014020213698N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014020213698N1.